Our mission is to measure and monitor steroid-toxicity, optimize treatment of inflammatory diseases, and improve the standard of care for millions of patients around the world. We developed the Steritas GTI (Glucocorticoid Toxicity Index) to enable clinicians to track the direct impact of steroid-toxicity. Today, the GTI provides a precise measure of the efficacy and safety of new therapies that treat inflammatory diseases and minimize the side-effects associated with glucocorticoid use. We aim to provide clinicians and patients the ability to track steroid-toxicity so they can taper steroid usage, and optimize treatment for the best possible outcomes.